Ginkgolide B Reduces Atherogenesis and Vascular Inflammation in ApoE−/− Mice
Open Access
- 11 May 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (5) , e36237
Abstract
To investigate whether ginkgolide B (a platelet-activating factor inhibitor) affects vascular inflammation in atherosclerosis-prone apolipoprotein E-deficient (ApoE−/−) mice. Human platelets were used to evaluate the effects of ginkgolide B on platelet aggregation and signal transduction. Ginkgolide B attenuated platelet aggregation and inhibited phosphatidylinositol 3 kinase (PI3K) activation and Akt phosphorylation in thrombin- and collagen-activated platelets. ApoE−/− mice were administered a high-cholesterol diet for 8 weeks. Plasma platelet factor 4 (PF4) and RANTES (regulated upon activation, normal T-cell expressed, and secreted protein) were then measured using an enzyme-linked immunosorbent assay. Scanning electron microscopy and immunohistochemistry were used to determine atherosclerotic lesions. Ginkgolide B decreased plasma PF4 and RANTES levels in ApoE−/− mice. Scanning electron microscopic examination showed that ginkgolide B reduced aortic plaque in ApoE−/− mice. Immunohistochemistry analysis demonstrated that ginkgolide B diminished P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE−/− mice. Moreover, ginkgolide B suppressed macrophage and vascular cell adhesion protein 1 (VCAM-1) expression in aorta lesions in ApoE−/− mice. Similar effects were observed in aspirin-treated ApoE−/− mice. Ginkgolide B significantly reduced atherosclerotic lesions and P-selectin, PF4, RANTES, and CD40L expression in aortic plaque in ApoE−/− mice. The efficacy of ginkgolide B was similar to aspirin. These results provide direct evidence that ginkgolide B inhibits atherosclerosis, which may be associated with inhibition of the PI3K/Akt pathway in activated platelets.Keywords
This publication has 28 references indexed in Scilit:
- Platelet-activating factor induces cardioprotection in isolated rat heart akin to ischemic preconditioning: role of phosphoinositide 3-kinase and protein kinase C activationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Impaired platelet responses to thrombin and collagen in AKT-1–deficient miceBlood, 2004
- Platelet factor 4 (PF-4)–induced neutrophil adhesion is controlled by src-kinases, whereas PF-4–mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinaseBlood, 2004
- Platelet Factor 4 Enhances the Binding of Oxidized Low-density Lipoprotein to Vascular Wall CellsJournal of Biological Chemistry, 2003
- A Critical Role of Platelet Adhesion in the Initiation of Atherosclerotic Lesion FormationJournal of Experimental Medicine, 2002
- Direct Demonstration of P-Selectin– and VCAM-1–Dependent Mononuclear Cell Rolling in Early Atherosclerotic Lesions of Apolipoprotein E–Deficient MiceCirculation Research, 1999
- Absence of P-selectin delays fatty streak formation in mice.Journal of Clinical Investigation, 1997
- Platelet Factor 4: Production, Structure, and Physiologic and Immunologic ActionExperimental Biology and Medicine, 1991
- Inhibition of the metabolism of platelet activating factor (PAF-acether) by three specific antagonists from ginkgo bilobaBiochemical Pharmacology, 1987
- Proofs of involvement of PAF-acether in various immune disorders using BN 52021 (ginkgolide B): a powerful PAF-acether antagonist isolated from Ginkgo biloba L.1986